trial · primary record
Anti-VEGF Monoclonal Antibody
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 87 |
| Primary completion | 2029-04-12 |
| Primary endpoint | Progression-free survival |
| Registry ID | NCT07504588 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:36.029Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07504588
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.